日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Versatile CRISPR-Cas Tools for Gene Regulation in Zebrafish via an Enhanced Q Binary System

利用增强型Q二元系统构建的多功能CRISPR-Cas工具在斑马鱼中进行基因调控

Shi, Miaoyuan; Ge, Weiqi; Li, Changheng; Liu, Bin; Deng, Xiaoyi; Liu, Chengjie; Zheng, Meijun; Zhang, Pu; Li, Lei; Guo, Ying; Han, Yunqi; Yang, Yu; Yu, Yanxun V; Jin, Youngnam N

RS-STGCN: Regional-Synergy Spatio-Temporal Graph Convolutional Network for emotion recognition

RS-STGCN:用于情感识别的区域协同时空图卷积网络

Han, Yunqi; Chen, Yifan; Ruan, Hang; Song, Deqing; Xu, Haoxuan; Zhu, Haiqi

Identification of potential molecular targets of luteolin in the treatment of hepatocellular carcinoma based on network pharmacology and transcriptome sequencing technology

基于网络药理学和转录组测序技术鉴定木犀草素在肝细胞癌治疗中的潜在分子靶点

Han, Yunqi; Wu, Huijun; Zhang, Xin; Lv, Wei; Xiong, Yang; Tian, Xinyuan; Xiao, Yunfeng; Cui, Hongwei

PPAR γ changing ALDH1A3 content to regulate lipid metabolism and inhibit lung cancer cell growth.

PPARα通过改变ALDH1A3含量来调节脂质代谢并抑制肺癌细胞生长

Tian Xinyuan, Bai Xiaoping, Han Yunqi, Ye Yu, Peng Meiling, Cui Hongwei, Li Kai

Advances in the Mechanism of Luteolin against Hepatocellular Carcinoma Based on Bioinformatics and Network Pharmacology

基于生物信息学和网络药理学的木犀草素抗肝细胞癌机制研究进展

Han, Yunqi; Xiao, Yunfeng; Yu, Lei; Chen, Jing; Yang, Xudong; Cui, Hongwei; Liang, Junqing

CT-721, a Potent Bcr-Abl Inhibitor, Exhibits Excellent In Vitro and In Vivo Efficacy in the Treatment of Chronic Myeloid Leukemia

CT-721 是一种强效的 Bcr-Abl 抑制剂,在体外和体内治疗慢性粒细胞白血病方面均表现出优异的疗效。

Sun, Yinghui; Zhao, Na; Wang, Huan; Wu, Qiong; Han, Yunqi; Liu, Qichao; Wu, Mangang; Liu, Yuliang; Kong, Fansheng; Wang, He; Sun, Ying; Sun, Deguang; Jing, Lutao; Tang, Guojing; Hu, Yuandong; Xiao, Dengming; Luo, Hong; Han, Yongxin; Peng, Yong